Literature DB >> 26185652

Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease.

Kinue Katano1, Yutaka Takeda2, Mayumi Sugiura-Ogasawara1.   

Abstract

Uterine arteriovenous malformation (AVM) is rare but it can cause life-threatening genital bleeding. Conservative therapy with GnRHa can be a useful option for treating a uterine AVM presenting with a congenital heart disease shunt in hemodynamically stable patients.

Entities:  

Keywords:  Congenital heart disease; gonadotropin-releasing hormone agonist; uterine arteriovenous malformation

Year:  2015        PMID： 26185652      PMCID： PMC4498866          DOI： 10.1002/ccr3.233

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN： 2050-0904


  8 in total

1.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

2.  Immunohistochemistry of vascular changes in leuprolide acetate-treated leiomyomas.

Authors:  A F Mesia; D Gahr; M Wild; K Mittal; R I Demopoulos
Journal:  Am J Obstet Gynecol       Date:  1997-05       Impact factor: 8.661

3.  Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice.

Authors:  Timothy R Carlson; Yibing Yan; Xiaoqing Wu; Michael T Lam; Gale L Tang; Levi J Beverly; Louis M Messina; Anthony J Capobianco; Zena Werb; Rong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

Review 4.  Uterine arteriovenous malformations: a review of the current literature.

Authors:  Rosalie M Grivell; Kym M Reid; Amy Mellor
Journal:  Obstet Gynecol Surv       Date:  2005-11       Impact factor: 2.347

5.  Resolution of uterine arteriovenous malformation and successful pregnancy after treatment with a gonadotropin-releasing hormone agonist.

Authors:  Taro Nonaka; Tetsuro Yahata; Katsunori Kashima; Kenichi Tanaka
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

Review 6.  Uterine arteriovenous malformations induced after diagnostic curettage: a systematic review.

Authors:  Panagiotis Peitsidis; Emmanouil Manolakos; Vasiliki Tsekoura; Rolf Kreienberg; Lukas Schwentner
Journal:  Arch Gynecol Obstet       Date:  2011-09-09       Impact factor: 2.344

7.  Embolization of uterine arteriovenous malformations associated with cyanotic congenital heart disease.

Authors:  N T Wijesekera; S P Padley; F Kazmi; C L Davies; J M McCall
Journal:  Cardiovasc Intervent Radiol       Date:  2009-05-07       Impact factor: 2.740

8.  VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy.

Authors:  Minah Kim; Hyeung Ju Park; Jae Won Seol; Jeon Yeob Jang; Young-Suk Cho; Kyu Rae Kim; Youngsok Choi; John P Lydon; Francesco J Demayo; Masabumi Shibuya; Napoleone Ferrara; Hoon-Ki Sung; Andras Nagy; Kari Alitalo; Gou Young Koh
Journal:  EMBO Mol Med       Date:  2013-08-02       Impact factor: 12.137
  8 in total
  1 in total

1.  Trans-arterial embolization of acquired uterine arteriovenous malformation after Cesarean section: A case series.

Authors:  Achmad Kemal Harzif; O G Rei; Agrifa Haloho; Melisa Silvia; Gita Pratama; Yuditiya Purwosunu; Aria Wibawa; Prijo Sidipratomo; Jacub Pandelaki
Journal:  Int J Reprod Biomed       Date:  2019-03-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.